Becton, Dickinson and Company BDX

183.82 4.59 2.56% as of 25 Sep
Market cap
$48.8B
P/E
55.4×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Becton, Dickinson and Company (BDX) Gross margin

Becton, Dickinson and Company's gross margin over the twelve months to 30 June 2026 was 46.7%, up 1.3 percentage points from fiscal 2025 (45.4%). Over the past ten years it has ranged from 42.2% (fiscal 2023) to 49.3% (fiscal 2017); the current reading is higher than 55% of that period. That is below the Medical Instruments & Supplies industry median of 54.6% and below the Healthcare sector median of 53.7%.

Gross margin, annual

Annual

Period Gross margin Change (points)
FY2025 45.4% 0.22
FY2024 45.2% 3.05
FY2023 42.2% (2.75)
FY2022 44.9% (0.20)
FY2021 45.1% 2.83
FY2020 42.3% (5.65)
FY2019 47.9% 2.46
FY2018 45.5% (3.85)
FY2017 49.3% 1.34
FY2016 48.0% 2.33

Quarterly

Period Gross margin Change (points)
Jun 2026 46.5% 0.77
Mar 2026 45.7% (0.22)
Dec 2025 45.9% (2.23)
Sep 2025 48.1% 0.85
42 more quarters

Against its own ten years

Low 42.2% High 49.3%
Ten-year median 45.4%
Current reading's percentile 55

Gross margin against peers

Company Gross margin
ISRG Intuitive Surgical, Inc. compare 66.7%
RMD ResMed Inc. compare 61.1%
ALC Alcon compare 56.9%
SOLV Solventum Corporation compare 54.7%
RGEN Repligen Corporation compare 53.5%
BDX Becton, Dickinson and Company 46.7%
MDLN Medline Inc. compare 46.3%
WST West Pharmaceutical Services, Inc. compare 36.8%
BAX Baxter International Inc. compare 30.1%
Medical Instruments & Supplies industry median 54.6%
Healthcare sector median 53.7%
Market median 46.3%

What Gross margin is

Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.

Gross Profit ÷ Revenue

The full definition of Gross margin →

More on BDX